How TEPEZZA Works for Thyroid Eye Disease and Which Patients May Be Candidates

Not every thyroid eye disease symptom means the same thing. Some patients mainly struggle with dryness and irritation. Others deal with bulging, pressure, swelling, or double vision that changes how they look and function day to day. That is why treatment conversations can feel conusing at first. Many people know about eye drops. Fewer know that there is also a medication designed to treat thyroid eye disease itself, not just the surface symptoms. That medication is TEPEZZA.

A quick refresher: thyroid eye disease (TED) is an autoimmune condition that affects the tissues around the eyes, including the muscles and fat behind the eye. It is most often linked to Graves’ disease, but it can also occur in people with normal or low thyroid levels. When TED becomes more active, patients may notice dry eyes, redness, swelling, bulging, pressure, pain with eye movement, or double vision.

Below is a simple guide to what TEPEZZA is, how it works, and when it may come up in treatment discussions.

1. TEPEZZA is a medical treatment for thyroid eye disease itself

TEPEZZA is the brand name for teprotumumab-trbw. According to the current FDA prescribing information, it is indicated for the treatment of thyroid eye disease regardless of disease activity or duration. That matters because TEPEZZA is not just another dry-eye treatment or anti-redness drop. It is a prescription IV medication used when the goal is to treat the broader TED process.

In practical terms, TEPEZZA usually comes up when a patient’s problem is bigger than surface irritation alone. A person may have prominent eyes, swelling, pressure, or double vision and want to know whether there is a treatment aimed at the disease itself, not just temporary symptom relief. That is where TEPEZZA becomes part of the conversation.

Why this matters: Some TED patients spend a long time thinking the only options are eye drops, ointment, or surgery. TEPEZZA changed that conversation because it gave patients a nonsurgical medical treatment option for TED.

2. TEPEZZA is not the same as a treatment for dry eye

This distinction is important. If your main problem is mild dryness from exposure, then lubrication and surface protection may still be a major part of treatment. But if TED is also causing bulging, swelling, pressure, or double vision, then the treatment discussion may need to go beyond the surface of the eye.

That is why doctors do not usually ask only, “Are your eyes dry?” They also ask whether your eyes look more prominent, whether your lids are more retracted, whether your eyes feel pressured, and whether you are developing double vision or trouble focusing with both eyes together. Those details help determine whether the disease seems to be affecting the eye surface, the tissues behind the eye, or both.

Why this matters: A patient can absolutely have severe dryness and still need more than eye drops if TED is active in deeper tissues around the eye.

3. TEPEZZA is given as a series of infusions, not a daily pill

TEPEZZA is given by IV infusion. The FDA label recommends 8 infusions total, with one infusion every 3 weeks. The official TEPEZZA patient information also explains that this full course usually takes about 5 months.

That schedule matters because patients often ask whether this is a one-time treatment or something they have to take every day. It is neither. It is a structured infusion course. The first two infusions generally take about 90 minutes each, and later infusions may take about 60 minutes, though timing can vary depending on how the patient responds.

Why this matters: TEPEZZA is a commitment. It is not something casually “tried” like over-the-counter drops. Patients need to know what the treatment course actually looks like before deciding whether to move forward.

4. Some patients may be candidates because of what TED is doing to their eyes

There is no single sentence that automatically makes someone a candidate. Instead, candidacy depends on the pattern and impact of the disease. In general, TEPEZZA tends to come up when TED is doing more than causing mild irritation. Patients may have noticeable bulging, swelling, pressure, discomfort, or double vision that is affecting daily life. AAO describes TEPEZZA as an important nonsurgical treatment option for thyroid eye disease, especially in patients with clinically significant disease.

A patient may want to ask about TEPEZZA if:

• the eyes look more prominent than before

• swelling and pressure are becoming more noticeable

• double vision is appearing or getting worse

• symptoms are affecting reading, driving, work, or confidence

• ordinary supportive care is not addressing the bigger TED picture

Why this matters: “Candidate” does not just mean “has TED.” It usually means the doctor is looking at how much TED is affecting function, appearance, and overall disease burden.

5. Not every patient with TED will be the right fit

This is the part patients need to hear clearly. TEPEZZA can be a very important option, but it is not automatically right for every person with thyroid eye disease. The FDA label includes important warnings and precautions, including infusion reactions, hyperglycemia, hearing impairment, and the possibility of inflammatory bowel disease flare.

That means candidacy depends on more than just eye symptoms. It also depends on medical history, risk factors, other conditions, and whether the likely benefits outweigh the potential downsides for that specific patient. This is one reason specialist evaluation matters so much. A person may be excited about the idea of a disease-directed treatment, but the right next step is still a careful, individualized discussion.

Why this matters: The best TED treatment is not always the newest one. It is the one that makes sense for the patient in front of you.

6. TEPEZZA is often part of a bigger treatment plan, not the whole plan by itself

Even when TEPEZZA is a strong option, many patients still need supportive care for the eye surface. Dryness, exposure, and corneal irritation may still need treatment with artificial tears, ointment, or other surface-protective measures. Some patients may also need prism glasses, steroids, or surgery depending on the pattern and stage of their TED.

This is why TED treatment often works in layers. One part of the plan may focus on the disease process. Another part may focus on protecting the front of the eye. Another part may focus on vision function or alignment. Patients are often relieved to hear that treatment does not have to be all-or-nothing.

Why this matters: Asking about TEPEZZA does not mean you are ruling out all other treatments. It means you are making sure disease-directed treatment is part of the conversation when appropriate.

Why early discussion matters

Patients do not need to wait until thyroid eye disease feels extreme before asking about treatment options. In fact, waiting too long can make the whole process more frustrating. Earlier evaluation helps clarify whether symptoms mainly reflect dryness, more active TED, or a combination of both. It also helps patients understand what options exist before they spend months assuming the only answer is “keep using more drops.”

The most important thing is not to self-select out of the conversation. A lot of patients assume they are “not bad enough,” or assume that if they are not in an emergency, there is nothing meaningful to ask about yet. That is not always true. Sometimes the right time to discuss TEPEZZA is when the disease is clearly affecting comfort, appearance, or function — before patients feel completely overwhelmed by it.

Treatments available

If TED is mild, treatment may start with:

• preservative-free artificial tears

• nighttime ointment

• cool compresses

• surface protection and monitoring

If the surface of the eye is significantly damaged from exposure and inflammation, additional surface-healing treatment may be considered. If the disease itself is more clinically significant, TEPEZZA may be one of the major medical options discussed. The right plan depends on the patient’s symptoms, exam findings, and overall health profile.

What to do if you think TEPEZZA may be worth asking about

If you have thyroid eye disease and are dealing with:

• bulging or more prominent eyes

• swelling or pressure

• worsening double vision

• symptoms that are affecting daily life

• the feeling that eye drops are not addressing the bigger problem

it may be time to ask whether a disease-directed treatment should be part of the discussion.

Action steps

Schedule an evaluation, bring up any history of Graves’ disease or thyroid problems, and be specific about what is changing — not just dryness, but also bulging, swelling, pressure, or double vision. That gives your doctor a much better sense of whether TEPEZZA belongs in the conversation.

What this means for your eyes

TEPEZZA is not for every patient with TED, but it is an important option that many patients do not know exists until much later than they should. The real question is not whether you have heard of it before. The real question is whether your symptoms suggest thyroid eye disease is affecting more than the surface of your eye — and whether a disease-directed treatment evaluation makes sense for you.

Book with us

If you have thyroid eye disease and want to know whether TEPEZZA may be an option in your case, book an evaluation with our team.

Request Appointment